TVA Medical | Transforming Vascular Access. Changing Lives.

Percutaneous System for Creating AVF for Hemodialysis

TVA Medical, Inc. has developed a catheter-based system for the creation of an arteriovenous fistula in patients requiring hemodialysis. For millions of patients worldwide receiving hemodialysis therapy, TVA Medical intends to transform the open surgical procedure into a minimally invasive procedure by using a catheter-based approach.

 

everlinQ™ is not available for sale in the United States. everlinQ has received European CE Mark approval for the creation of an arteriovenous fistula in patients with chronic kidney disease requiring hemodialysis.